BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22578948)

  • 1. Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study.
    Yadegari H; Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Cardiol; 2013 Aug; 167(4):1486-94. PubMed ID: 22578948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study.
    Samadi S; Bozorgmanesh M; Khalili D; Momenan A; Sheikholeslami F; Azizi F; Hadaegh F
    Int J Cardiol; 2013 May; 165(2):260-5. PubMed ID: 21924777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran lipid and glucose study.
    Mohammadreza B; Farzad H; Davoud K; Fereidoun Prof AF
    Cardiovasc Diabetol; 2012 Mar; 11():20. PubMed ID: 22394430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
    Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
    J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study.
    Bozorgmanesh M; Hadaegh F; Saadat N; Azizi F
    Acta Diabetol; 2012 Oct; 49(5):341-8. PubMed ID: 21617883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CVD-predictive performances of "a body shape index" versus simple anthropometric measures: Tehran lipid and glucose study.
    Bozorgmanesh M; Sardarinia M; Hajsheikholeslami F; Azizi F; Hadaegh F
    Eur J Nutr; 2016 Feb; 55(1):147-57. PubMed ID: 25596850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
    Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study.
    Barzin M; Hosseinpanah F; Malboosbaf R; Hajsheikholeslami F; Azizi F
    Diab Vasc Dis Res; 2013 Jul; 10(4):324-9. PubMed ID: 23291339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
    Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Rambod M; Reza Ghaffari HR; Azizi F
    Diabet Med; 2006 Sep; 23(9):982-9. PubMed ID: 16922704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J-shaped association between plasma glucose concentration and cardiovascular disease mortality over a follow-up of 32years.
    von Gunten E; Braun J; Bopp M; Keller U; Faeh D
    Prev Med; 2013 Nov; 57(5):623-8. PubMed ID: 23994156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
    Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
    Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision tree-based modelling for identification of potential interactions between type 2 diabetes risk factors: a decade follow-up in a Middle East prospective cohort study.
    Ramezankhani A; Hadavandi E; Pournik O; Shahrabi J; Azizi F; Hadaegh F
    BMJ Open; 2016 Dec; 6(12):e013336. PubMed ID: 27909038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between fasting plasma glucose and all-cause and cause-specific mortality by gender: The rural Chinese cohort study.
    Liu L; Chen X; Liu Y; Sun X; Yin Z; Li H; Zhang M; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Zhang D; Cheng C; Liu F; Zhou Q; Xu Q; Xiong Y; Liu J; You Z; Hong S; Wang C; Hu D
    Diabetes Metab Res Rev; 2019 May; 35(4):e3129. PubMed ID: 30657630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III.
    Zalawadiya SK; Veeranna V; Mallikethi-Reddy S; Bavishi C; Lunagaria A; Kottam A; Afonso L
    Eur J Prev Cardiol; 2015 Apr; 22(4):513-8. PubMed ID: 24431384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study.
    Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
    Am Heart J; 2008 Nov; 156(5):996-1002. PubMed ID: 19061718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.
    Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
    J Intern Med; 2010 Jun; 267(6):561-6. PubMed ID: 20337857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.